Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Clinical trial NCT01250366 · COMPLETED

Trial details

NCT number: NCT01250366
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HCV (Genotype 1)

Start date: 2010-10-01
Primary completion: 2011-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.